Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: S01XA18

Ikervis(ciclosporin)

Corneal Diseases

Marketing Authorisation Holder: Santen Oy

EMA Authorisation: 19/03/2015

INN: ciclosporin

Indication

Treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Ikervis — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.